-
Ten Points to be Watched in the New Edition of GMP for Veterinary Drugs
PharmaSources/zhulikou431
October 25, 2019
The Veterinary Bureau of the Ministry of Agriculture and Rural Affairs of the People’s Republic of China issued the Soliciting Public Opinions on the Good Manufacturing Practice for Veterinary Drugs (Revised Draft for Comment) on June 14, 2019, which is s
-
With the Approval of World’s First Oral GLP-1 Receptor Agonist, Novo Nordisk Maintains its Dominance in the Diabetes Area
PharmaSources/Dopine
October 25, 2019
FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form on Sept. 20th.With the approval of this world’s first Oral GLP-1 Receptor Agonist, Novo Nordisk maintains its dominance in the diabetes area.
-
Sales of Toripalimab and Sintilimab Both Exceeded RMB300 Million
PharmaSources/Xiaoyaowan
October 24, 2019
Junshi Biosciences’ toripalimab and Innovent’s sintilimab were successively approved in Dec. 2018, to become the first Chinese-produced anti-PD-1 monoclonal antibodies marketed.
-
Interview with Guilin Nuti Ingredients: We Assure Purity, Quality and Reliability
En-CPhI.CN
October 08, 2019
Established in Guilin, China, specialized in plant extraction, with the experience over 15 years, Guilin Nuti Ingredients Corp. manufactures and extracts natural active ingredients for medicinal and cosmetic purposes.
-
Naturalness and Healthiness Offering the Company Stronger International Competitiveness
en-cphi.cn
September 17, 2019
Anhui Hegeng Biotech Engineering Co., Ltd. (“Hegeng Biotech”) received an interview after the CPhI.Core products mainly brought by Hegeng Biotech to the CPhI this year included L-arabinose ...
-
Understanding Biofilm Lifecycle and Remediation Procedures
PharmaSources/Richard Chai
September 06, 2019
Biofilm formation in process equipment presents challenges and may lead to serious consequences in GMP related manufacturing.
-
Chemotherapy is Out-of-date? Global Chemotherapy Demands will be Doubled in 2040, with China Having the Highest Demands!
PharmaSources/Yefenghong
September 04, 2019
Many people consider that the status of chemotherapy in cancer treatment has fallen considerably and some even consider chemotherapy to be out-of-date in recent years with the occurrence of targeted drugs and immunotherapy. Is chemotherapy useless?
-
Novartis’ CTL019 Applied for Clinical Trial in China to Officially Enter the Chinese Market
PharmaSources/Xiaoyaowan
August 27, 2019
Novartis develops the world’s first CAR T-cell therapy CTL019. And now the drug has been accepted by the CDE.
-
A New Favorite in the Medical World: Epigenetic Drugs
PharmaSources/Yefenghong
August 21, 2019
Epigenetics was coined by Conrad Waddington, a British developmental biologist, in the 1950s to describe the interactions between the environment and the genes in the developmental process...
-
“Upstar” against Breast Cancer—CDK 4/6 Inhibitors: Which has the Biggest Potential among the Three?
PharmaSources/Dopine
August 20, 2019
Targeted therapies have played an increasingly important role in tumor treatment in recent years.